Sept. 23, 2018
Here Monty and Desiree present part of Professor Paul Myles's EBPOM 2018 presentation regarding the RELIEF trial, a massive part of the perioperative calendar this year. What are the consequences of this trial for the practice of Enhanced Recovery After Surgery (ERAS)? Also hear more about the follow up trial which will be looking at Acute Kidney Injury (AKI). This then leads to discussion of the OPTIMISE II trial.
Discussion then leads into the FEDORA trial and the IMPRESS trial with a clip of Monty's talk from EBPOM 2018.
Presented by Monty Mythen and Desiree Chappell with contributions from Professor Paul Myles Head of Alfred Health's and Monash University's Department of Anaesthesia and Perioperative Medicine and Professor Rupert Pearse, Intensive Care Medicine at Queen Mary, University of London.
This special programme was originally streamed live on www.topmedtalk.com - if you missed it you're obviously not yet signed up to our newsletter. Go to the website or follow this link: https://www.topmedtalk.com/sign-up/
